Experimental, Molecular Docking Investigations and Bioavailability Study on the Inclusion Complexes of Finasteride and Cyclodextrins
June 2017
in “
DOAJ (DOAJ: Directory of Open Access Journals)
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that finasteride's solubility and bioavailability were improved when using a dimethyl-β-cyclodextrin inclusion complex compared to the drug alone.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated the inclusion complexes of finasteride (FIN) with various β-cyclodextrins (β-CyDs) to enhance its solubility and bioavailability. Using differential scanning calorimetry, infrared spectroscopy, X-ray diffractometry, and dissolution studies, the researchers found that the dimethyl-β-cyclodextrin (DM-β-CyD) inclusion system provided the highest complexation efficiency. Molecular docking confirmed the suitable arrangement of FIN within the β-CyD cavity. Pharmacokinetic analysis showed that the FIN/DM-β-CyD complex had a higher absorption rate and greater area under the curve compared to FIN alone, indicating improved absorption and bioavailability.
